Are you sure?

Bankár Holding stake in Phylaxia falls under 10%

Drug maker Phylaxia 1912 Holding said Bankár Holding's stake in it fell to 9.85% after the sale of shares on October 13.

Bankár Holding subscribed 5 million newly issued Phylaxia shares -- conferring a 13.51% ownership stake -- in July, providing Phylaxia with the liquidity to purchase 750,000 shares and an equal number of warrants in New York-based N-GENE Research Laboratories, a company set up by investors and Hungarian researchers to develop a drug that could increase insulin sensitivity for people with type-2 diabetes. (MTI – Econews)